A detailed history of Personal Cfo Solutions, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 11,315 shares of ABBV stock, worth $2.04 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
11,315
Previous 11,377 0.54%
Holding current value
$2.04 Million
Previous $1.95 Million 14.51%
% of portfolio
0.32%
Previous 0.31%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $10,158 - $12,358
-62 Reduced 0.54%
11,315 $2.23 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $7,429 - $8,676
48 Added 0.42%
11,377 $1.95 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $48,265 - $54,994
302 Added 2.74%
11,329 $2.06 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $651,948 - $734,247
4,738 Added 75.34%
11,027 $1.71 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $64,791 - $75,005
485 Added 8.36%
6,289 $937,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $12,985 - $16,160
-98 Reduced 1.66%
5,804 $781,000
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $46,130 - $53,126
319 Added 5.71%
5,902 $940,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $57,122 - $68,504
413 Added 7.99%
5,583 $902,000
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $19,728 - $22,627
147 Added 2.93%
5,170 $694,000
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $29,725 - $37,791
216 Added 4.49%
5,023 $769,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $83,939 - $104,145
636 Added 15.25%
4,807 $779,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $143,956 - $182,146
-1,340 Reduced 24.32%
4,171 $565,000
Q3 2021

Nov 18, 2021

BUY
$106.4 - $120.78 $165,239 - $187,571
1,553 Added 39.24%
5,511 $595,000
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $4,208 - $4,688
40 Added 1.02%
3,958 $446,000
Q1 2021

Apr 21, 2021

SELL
$102.3 - $112.62 $50,024 - $55,071
-489 Reduced 11.1%
3,918 $424,000
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $13,361 - $18,039
-166 Reduced 3.63%
4,407 $472,000
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $28,693 - $33,677
334 Added 7.88%
4,573 $0
Q2 2020

Aug 03, 2020

SELL
$73.37 - $98.18 $114,603 - $153,357
-1,562 Reduced 26.93%
4,239 $416,000
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $195,757 - $296,792
3,035 Added 109.73%
5,801 $442,000
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $174,202 - $209,441
2,766 New
2,766 $209,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.